November 14, 2017
New York, NY
Panelist : Norman Shelby
Real Endpoints LLC
Immuno-oncology treatments have provided renewed hope to cancer patients. Combination treatments bring the promise of increased efficacy with manageable side effects. Come hear from experts about what the future may bring.
Moderator Norman Selby, Board of Trustees at Memorial Sloan Kettering, Executive Chairman of RealEndpoints and PAIGE.AI, former Senior Partner at McKinsey.
Panelists: Sophie Opdyke, VP, Immuno-Oncology Lead, Global Commercial Development at Pfizer Umer Raffat, Managing Director at Evercore ISI Peter Bach, Director, Center for Health Policy and Outcomes at MSK.
view event >November 17, 2023
Chicago, IL
Rob O'Brien, SVP Specialty
A day-long meeting in Chicago focused on healthcare and pharmaceutical marketplace trends, including a review of the specialty pipeline, implications of the IRA, and potential pharmaceutical disruptions. Rob O’Brien, SVP of Specialty, presenting.
October 19, 2023 - October 20, 2023
Las Vegas, NV
Jane Barlow, Chief Clinical Officer
A meeting of healthcare executives representing integrated delivery networks, managed care nurses, and medical directors.
October 18, 2023 - October 20, 2023
New York, NY
Susan Raiola, President
Stakeholders in the cancer care ecosystem meet to discuss issues linked to cost, quality, and access. RE President, Susan Raiola, will be speaking on patient support.
October 10, 2023 - October 12, 2023
Orlando, FL
Rob O'Brien, SVP Specialty
Pharma and payer execs gather to discuss the future of managed care pharmacy. Rob O’Brien provides a perspective on the self-insured employer market.
October 8, 2023 - October 10, 2023
Carlsbad, CA
Roger Longman, Co-Founder and Chairman
Top biotech CEOs gather from around the globe to discuss pressing industry issues. Roger Longman, Co-founder and Chairman, is participating.
September 24, 2023 - August 26, 2023
Zurich, Switzerland
Jeff Berkowitz, CEO
An annual summit hosted by HBM to exchange views about the latest developments in the biopharma industry. Jeff Berkowitz, CEO of Real Endpoints, will provide an overview of why market access matters now, more than ever.
Manager
Payer & Channel Insights, Marketing Analytics & Business Insights